These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9717816

  • 61. Rationale and practice of testing chemotherapeutic agents for prostate cancer.
    Sandberg AA.
    Urology; 1981 Apr; 17(4 Suppl):34-44. PubMed ID: 7210392
    [No Abstract] [Full Text] [Related]

  • 62. Proapoptotic effects of new pentabromobenzylisothiouronium salts in a human prostate adenocarcinoma cell line.
    Koronkiewicz M, Kazimierczuk Z, Szarpak K, Chilmonczyk Z.
    Acta Pol Pharm; 2012 Apr; 69(6):1325-33. PubMed ID: 23285698
    [Abstract] [Full Text] [Related]

  • 63. Preclinical and clinical studies with the multi-kinase inhibitor CEP-701 as treatment for prostate cancer demonstrate the inadequacy of PSA response as a primary endpoint.
    Collins C, Carducci MA, Eisenberger MA, Isaacs JT, Partin AW, Pili R, Sinibaldi VJ, Walczak JS, Denmeade SR.
    Cancer Biol Ther; 2007 Sep; 6(9):1360-7. PubMed ID: 17786033
    [Abstract] [Full Text] [Related]

  • 64. Expression of Trk receptors during cartilage differentiation.
    Mitsiadis TA, Wroblewski J, Urdiales JL, Becker E, Martin-Zanca D, Rudkin BB, Lendahl U.
    Ann N Y Acad Sci; 1996 Jun 08; 785():298-300. PubMed ID: 8702160
    [No Abstract] [Full Text] [Related]

  • 65. The evaluation of heparin in control of metastasis of Nb rat androgen-insensitive prostate carcinoma.
    Drago JR, Weed P, Fralisch A.
    Anticancer Res; 1984 Jun 08; 4(3):171-2. PubMed ID: 6540544
    [Abstract] [Full Text] [Related]

  • 66. Prostate carcinoma of the Nb rat in relation to hormones.
    Noble RL.
    Int Rev Exp Pathol; 1982 Jun 08; 23():113-59. PubMed ID: 7045013
    [No Abstract] [Full Text] [Related]

  • 67. Effect of LS 1727, a nitrosocarbamate of 19-nortestosterone, on the R-3327 rat prostatic adenocarcinoma.
    Müntzing J, Kirdani RY, Williams PD, Murphy GP.
    Res Commun Chem Pathol Pharmacol; 1981 May 08; 32(2):309-16. PubMed ID: 7244365
    [Abstract] [Full Text] [Related]

  • 68. Soy extract reduces prostate cancer growth in mice, cell culture.
    Urol Nurs; 2001 Dec 08; 21(6):411-2. PubMed ID: 11998508
    [No Abstract] [Full Text] [Related]

  • 69. Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
    Sartore-Bianchi A, Ardini E, Bosotti R, Amatu A, Valtorta E, Somaschini A, Raddrizzani L, Palmeri L, Banfi P, Bonazzina E, Misale S, Marrapese G, Leone A, Alzani R, Luo D, Hornby Z, Lim J, Veronese S, Vanzulli A, Bardelli A, Martignoni M, Davite C, Galvani A, Isacchi A, Siena S.
    J Natl Cancer Inst; 2016 Jan 08; 108(1):. PubMed ID: 26563355
    [Abstract] [Full Text] [Related]

  • 70. Four cardiac hormones cause death of human cancer cells but not of healthy cells.
    Skelton WP, Pi GE, Vesely DL.
    Anticancer Res; 2011 Feb 08; 31(2):395-402. PubMed ID: 21378317
    [Abstract] [Full Text] [Related]

  • 71. The LNCaP cell line--a new model for studies on human prostatic carcinoma.
    Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim U, Chai LS, Kakati S, Arya SK, Sandberg AA.
    Prog Clin Biol Res; 1980 Feb 08; 37():115-32. PubMed ID: 7384082
    [No Abstract] [Full Text] [Related]

  • 72. Role of neurotrophin-trk interactions in oncology: the anti-tumor efficacy of potent and selective trk tyrosine kinase inhibitors in pre-clinical tumor models.
    Ruggeri BA, Miknyoczki SJ, Singh J, Hudkins RL.
    Curr Med Chem; 1999 Sep 08; 6(9):845-57. PubMed ID: 10495355
    [Abstract] [Full Text] [Related]

  • 73. Novel agents and new therapeutics in castration-resistant prostate cancer.
    Wu Y, Rosenberg JE, Taplin ME.
    Curr Opin Oncol; 2011 May 08; 23(3):290-6. PubMed ID: 21311328
    [Abstract] [Full Text] [Related]

  • 74. New agents for prostate cancer.
    Reese DM.
    Hematol Oncol Clin North Am; 2001 Jun 08; 15(3):547-57. PubMed ID: 11525296
    [Abstract] [Full Text] [Related]

  • 75. Animal model of human disease: metastic adenocarcinoma of the prostate.
    Pollard M.
    Am J Pathol; 1977 Jan 08; 86(1):277-80. PubMed ID: 831516
    [No Abstract] [Full Text] [Related]

  • 76. Nonreceptor tyrosine kinases in prostate cancer.
    Chang YM, Kung HJ, Evans CP.
    Neoplasia; 2007 Feb 08; 9(2):90-100. PubMed ID: 17357254
    [Abstract] [Full Text] [Related]

  • 77. 1-dehydro-melengestrol acetate inhibits the growth and protein kinase C activity of androgen-independent Dunning rat prostatic tumors.
    Battistone MJ, Padilla GM, Petrow V.
    Cancer Chemother Pharmacol; 1993 Feb 08; 31(5):407-11. PubMed ID: 8431975
    [Abstract] [Full Text] [Related]

  • 78. Metastasis of rat prostate adenocarcinoma cells.
    Pollard M, Chan SY.
    Prog Clin Biol Res; 1981 Feb 08; 75B():249-56. PubMed ID: 6798581
    [No Abstract] [Full Text] [Related]

  • 79. A chemical genomics approach to drug reprofiling in oncology: Antipsychotic drug risperidone as a potential adenocarcinoma treatment.
    Dilly SJ, Clark AJ, Marsh A, Mitchell DA, Cain R, Fishwick CWG, Taylor PC.
    Cancer Lett; 2017 May 01; 393():16-21. PubMed ID: 28188816
    [Abstract] [Full Text] [Related]

  • 80. Chemotherapy of Nb rat adenocarcinoma of the prostate heterotransplanted into congenitally athymic (nude) mice: report of 5-fluorouracil and cyclophosphamide.
    Drago JR, Maurer RE, Gershwin ME, Eckels DD, Goldman LB.
    J Surg Res; 1979 Apr 01; 26(4):400-3. PubMed ID: 431058
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.